About Us
A pharmacy with world-class service.
Who we are
Genetrump Co., Ltd.
Genetrump Co., Ltd. was founded in 2018 by the team of Professor Wang Chunming of the State Key Laboratory of Quality Research in Chinese Medicines at the University of Macau. The legal representative is Zhang Zhe, and the actual controlling shareholder is Wang Chunming. Its main business field is the field of natural polysaccharide active molecules.
Mainly based on the world's leading natural polysaccharide extraction platform and the two core technology platforms of polysaccharide directional enzymatic hydrolysis and modification, Jinchuangke has established a full industry chain business system from raw materials to medical terminal products and functional skin care products to serve the world. Pharmaceutical, cosmetics, food and health product manufacturing companies, medical institutions and end users.
As an advanced natural polysaccharide active molecule development enterprise in the industry, Jinchuangke takes root in Macau and the Greater Bay Area. It uses active natural polysaccharide molecules with advanced preparation technology to break the foreign technology monopoly in the field of polysaccharide extraction and functional modification, and develops China's own of high-performance polysaccharide molecules. Jinchuangke is determined to become a leading company in the field of polysaccharide active molecules and polysaccharide drugs.
Why choose us
企业使命与愿景
Combining my country's precious natural polysaccharide resources with modern advanced modification and preparation technologies, we develop new active polysaccharide products to bring human beings a new experience of health, beauty, and happiness.
Develop my country's precious natural polysaccharide resources, develop biological polysaccharide molecules with excellent biological functions for downstream enterprises and consumers, break foreign technology monopoly in the extraction and modification of polysaccharide molecules, develop China's own active polysaccharide molecules, and establish China Own polysaccharide processing platform.
As the world's leading natural polysaccharide active product development company, we are rooted in Macau and the Greater Bay Area, developing products across the entire industry chain from raw materials to medical terminal products and functional skin care products. Make good Chinese products and become a powerful enterprise in the world.
Our Value
Corporate mission and vision
Combining my country's precious natural polysaccharide resources with modern advanced modification and preparation technologies, we develop new active polysaccharide products to bring human beings a new experience of health, beauty, and happiness.
Develop my country's precious natural polysaccharide resources, develop biological polysaccharide molecules with excellent biological functions for downstream enterprises and consumers, break foreign technology monopoly in the extraction and modification of polysaccharide molecules, develop China's own active polysaccharide molecules, and establish China Own polysaccharide processing platform.
As the world's leading natural polysaccharide active product development company, we are rooted in Macau and the Greater Bay Area, developing products across the entire industry chain from raw materials to medical terminal products and functional skin care products. Make good Chinese products and become a powerful enterprise in the world.
0756-6176330
Meet our team
Founding Team
Dr. Zhang Zhe
Executive Director
Degree Honors
University of Macau Master of Traditional Chinese Medicine
University of Macau, PhD in Biomedicine
Honors and Awards
Macau Science and Technology Award "Graduate Student Award"
First place in Macau Youth Entrepreneurship Competition
FDCT "Enterprise Innovation R&D Project"
Guangdong Province Maker Cup "Second Prize"
Professor Wang Chunming
Chief Scientist
Professor Wang Chunming received his bachelor's and master's degrees in biochemistry from Nanjing University (China) and engaged in biomaterials research in Professor Zhang Junfeng's laboratory. He received his PhD in Biomedical Engineering from Nanyang Technological University, Singapore, under the supervision of Professor Wang Dongan, and did postdoctoral training at the University of Cambridge (UK), in the group of Professor Wilhelm Huck in the Department of Chemistry and in the experiments of Professor Fiona Watt at the Wellcome Trust Stem Cell Research Centre. room work. He later assisted Dr Victor Nurcombe and Dr Simon Cool at the Institute of Medical Biology in Singapore on an industry-led translational project. In October 2012, he began to engage in independent research at the University of Macau as an assistant professor, and was promoted to associate professor in August 2018, and to professor in August 2022.
Currently, Professor Wang Chunming is also the director of UM’s Research Services and Knowledge Transfer Office (RSKTO). RSKTO combines the functions of many other institutions' research support offices and patent management departments to serve the UM community by overseeing a wide range of research-related matters at the university, from grant application and management to talent programs, collaboration agreements to patent applications and more. At the same time, Professor Wang Chunming also serves as the deputy director of the Zhuhai UM Science and Technology Research Institute (ZUMRI), which is the driving force for UM’s industry-university-research cooperation in the Greater Bay Area. In addition, Professor Wang Chunming is also the co-founder of Genetrump Companhia Limitada (Macau), an award-winning spin-out company from UM that specializes in developing carbohydrate-based regenerative medicine therapies.
- 2020.10 – National Natural Science Foundation of China Distinguished Young Scholars Fund
- 2020.12 – ‘Qi-Huang’ Youth Scholarship, State Administration of Traditional Chinese Medicine, China
- 2021.01 – Fellow of the Royal Society of Biology
- 2021.04 – Fellow of the Royal Society of Chemistry
- 2023.08 – Sigma Xi, Research Honor Society (ΣΞ)
Research Direction
Cell and tissue microenvironments are like seeds and soil, and our goal is to optimize the soil to improve seed growth. We design and test biomaterial- or cell-based therapeutic strategies in a variety of models, from bone defects to limb ischemia to diabetic skin ulcers. We focus specifically on: i) (poly/oligo)glucomannan and its derivatives: studying structure-activity relationships and designing immunoactive biomaterials, and ii) designing "new" macrophages with repair functions.
So far, Professor Wang Chunming has received 20 research grants as a PI, mainly including:
- Macao's key R&D projects in 2022
- National Natural Science Foundation of China Outstanding Youth Fund, awarded in 2020
- Macau Science and Technology Development Fund (Portuguese abbreviation: FDCT): A total of 5 research grants have been received from 2013 to 2020.
- 2019 FDCT-NSFC joint sponsorship
- 2021年FDCT-GDST联合赞助
- Funded by Shenzhen Science and Technology Innovation Commission in 2021
- 2021 Huafa-UM Joint Translational Research Funding
- University of Macau Research Council
- 2 national key laboratories in mainland universities.
company team
Dr. Wang Anheng
Technical Director of Pharmaceutical Segment
Academic background and professional experience
PhD from the University of Hull and postdoctoral fellow at the Institute of Science and Technology of UM Zhuhai. He has rich experience in biology and emulsion development. He once worked at Hull York Medical School and was engaged in the research and development of technologies related to wound repair.
